Skip to content

Movement Enhancing Device for Children

An Innovative Device for Intervention in Infants With Nervous System Injury

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01959581
Enrollment
30
Registered
2013-10-10
Start date
2014-05-31
Completion date
2016-10-31
Last updated
2017-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Extremity Dysfunction

Keywords

Wilmington Robotic Exoskeleton, Reaching, Upper extremity function, Preterm Infants, Brain injury, Pediatrics, Early Intervention, Arthrogryposis

Brief summary

The purpose of this study is to assess: 1) how infants move their bodies to explore, play, and solve problems, 2) if this is different in a high-risk group of infants, and 3) if these abilities can be advanced in a high-risk group through the use of a movement assisting device.

Detailed description

Certain conditions or diagnoses identified soon after birth are known to put infants at risk for having problems with their motor (movement) development as they get older. Infants with these diagnoses are at risk for additional developmental problems due to their inability to move their bodies to explore, learn, and play. This study tests how a device that assists movement can help exploration, learning, and play in children. The information gathered in this study will help us better understand how early learning happens and how we can help individuals become better movers, learners, and problem-solvers so they can increase their participation in everyday play activities.

Interventions

DEVICEMovement Enhancing Device

Naturalistic play activities using the hands while wearing the movement enhancing device.

Sponsors

Christiana Care Health Services
CollaboratorOTHER
Alfred I. duPont Hospital for Children
CollaboratorOTHER
University of Delaware
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

Coders are blind to which study phase participants are in

Eligibility

Sex/Gender
ALL
Age
1 Months to 6 Years
Healthy volunteers
Yes

Inclusion criteria

• Infants will be invited to participate if they are between 1 month and 6 years and: * Were born \< 36 weeks of gestational age with periventricular leukomalacia or grade III or IV intraventricular hemorrhage * Were born \> 36 weeks of gestational age with encephalopathy related to perinatal asphyxia * Have the diagnosis of neonatal stroke or intracranial hemorrhage * Have brachial plexus palsy * Have arthrogryposis multiplex congenital * Have Down syndrome * Have congenital hypotonia

Exclusion criteria

• blindness or severe sensory motor impairments that would prohibit the child from completing the study assessment.

Design outcomes

Primary

MeasureTime frameDescription
Change in Time Contacting Objects7 monthsPercent of the assessment time participants are able to contact objects across different locations. Change within each session with versus without the exoskeleton donned. Slope of change across time in the intervention phase relative to in the baseline phase.

Countries

United States

Participant flow

Participants by arm

ArmCount
Movement Enhancing Device
Guided play while wearing a movement assisting device Movement Enhancing Device: Naturalistic play activities using the hands while wearing the movement enhancing device.
25
Total25

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up5

Baseline characteristics

CharacteristicMovement Enhancing Device
Age, Continuous2.37 months
STANDARD_DEVIATION 1.26
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
24 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
3 Participants
Race (NIH/OMB)
Black or African American
6 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
16 Participants
Region of Enrollment
United States
25 participants
Sex: Female, Male
Female
16 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 30
other
Total, other adverse events
0 / 30
serious
Total, serious adverse events
0 / 30

Outcome results

Primary

Change in Time Contacting Objects

Percent of the assessment time participants are able to contact objects across different locations. Change within each session with versus without the exoskeleton donned. Slope of change across time in the intervention phase relative to in the baseline phase.

Time frame: 7 months

Population: infants born with significant brain injury and toddlers with a diagnosis of arthrogryposis multiplex congenita

ArmMeasureValue (MEAN)Dispersion
Movement Enhancing DeviceChange in Time Contacting Objects40.75 percentage of timeStandard Deviation 30.06
Comparison: Repeated measures ANOVAp-value: <0.05ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026